Thus, apart from the previously studied role of leptin in AD, this study directs attention to adiponectin and resistin as the candidate adipokines possibly involved in shaping eczema severity, which may help predict disease exacerbations and develop targeted therapeutic interventions. The gene discussed is LEP; the disease is Eczematoid dermatitis.